Novel BCR-ABL1 tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia. Issue 11 (2nd November 2021)

Record Type:: Journal Article
Title:: Novel BCR-ABL1 tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia. Issue 11 (2nd November 2021)
Main Title:: Novel BCR-ABL1 tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia
Authors:: Malik, Sara
Hassan, Shahzeb
Eşkazan, Ahmet Emre
Abstract:
Is Part Of:: Expert review of hematology. Volume 14:Issue 11(2021)
Journal:: Expert review of hematology
Issue:: Volume 14:Issue 11(2021)
Issue Display:: Volume 14, Issue 11 (2021)
Year:: 2021
Volume:: 14
Issue:: 11
Issue Sort Value:: 2021-0014-0011-0000
Page Start:: 975
Page End:: 978
Publication Date:: 2021-11-02
Subjects:: Asciminib -- chronic myeloid leukemia -- flumatinib -- HQP1351 -- K0706 -- novel therapies -- olverembatinib -- PF-114 -- tyrosine kinase inhibitor -- vodobatinib
Hematology -- Periodicals
616.15005
Journal URLs:: http://www.expert-reviews.com/loi/ehm ↗
http://informahealthcare.com ↗
DOI:: 10.1080/17474086.2021.1990034 ↗
Languages:: English
ISSNs:: 1747-4086
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 9830.227000
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store
Ingest File:: 20294.xml